Original price was: $1,300.00.$799.00Current price is: $799.00.
In Stock
The World Health Organization (WHO) has recommended the drugs nirmatrelvir and ritonavir, sold under the name Paxlovid, for the treatment of COVID-19 patients with mild or non-severe illness but at high risk of hospitalization. WHO called this drug “the best therapeutic tool to date.”
Pfizer’s (2023) oral antiviral is recommended for patients who are most at risk of developing severe illness and hospitalization. This group includes the unvaccinated, the elderly, or people taking immune-suppressing drugs.
The recommendation is based on new data from two randomized controlled trials involving 3078 patients. The results show that the risk of hospitalization after such treatment is reduced by 85 %.
Active Ingredients: nirmatrelvir and ritonavir
Prescription medicine.
| Действующее вещество | нирматрелвир и ритонавир |
|---|---|
| Количество таблеток | 30 |
| Температура хранения | До 25 Градусов |
| Цена за доставку | До 2 Кг 50 Доларов |
